Column Capital Advisors’s Amgen AMGN Stock Holding History

Column Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$5.91K	Sell	22 -6	-21%	-$1.5K	﹤0.01%	586
2023 Q2	$6.22K	Sell	28 -7	-20%	-$1.62K	﹤0.01%	593
2023 Q1	$8.46K	Sell	35 -9	-20%	-$2.21K	﹤0.01%	581
2022 Q4	$11.6K	Buy	44 +9	+26%	+$2.41K	﹤0.01%	496
2022 Q3	$8K	Hold	35	–	–	﹤0.01%	492
2022 Q2	$9K	Hold	35	–	–	﹤0.01%	486
2022 Q1	$8K	Sell	35 -4	-10%	-$919	﹤0.01%	526
2021 Q4	$9K	Sell	39 -8	-17%	-$1.69K	﹤0.01%	516
2021 Q3	$10K	Sell	47 -2	-4%	-$460	﹤0.01%	464
2021 Q2	$12K	Sell	49 -6	-11%	-$1.48K	﹤0.01%	446
2021 Q1	$14K	Sell	55 -14	-20%	-$3.34K	﹤0.01%	411
2020 Q4	$16K	Hold	69	–	–	﹤0.01%	399
2020 Q3	$18K	Sell	69 -177	-72%	-$43.9K	0.01%	369
2020 Q2	$58K	Buy	246 +52	+27%	+$11.9K	0.02%	227
2020 Q1	$39K	Buy	194 +96	+98%	+$21K	0.02%	230
2019 Q4	$23K	Buy	+98	New	+$21.6K	0.01%	344

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Column Capital Advisors's AMGN Position: Q3 2023 in Review

Column Capital Advisors reduced its Amgen (AMGN) stake by 21% in Q3 2023, selling an estimated $1.5K and leaving 22 shares worth $5.91K. The position accounts for ﹤0.01% of the portfolio, ranked #586.

Column Capital Advisors first reported a position in AMGN in Q4 2019 and has held it in 16 quarters since. The position peaked at $58K in Q2 2020. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

Column Capital Advisors held 22 shares of Amgen worth $5.91K as of Q3 2023.
Column Capital Advisors sold 6 Amgen shares in Q3 2023, an estimated $1.5K.
Amgen made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #586 holding.
Column Capital Advisors first reported a position in Amgen in Q4 2019 and has held it in 16 quarters since.
Column Capital Advisors's Amgen position peaked at $58K in Q2 2020.
2,502 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.